December 4, 2017 – The U.S. Food and Drug Administration (FDA) on December 4 released a new set of recommendations for creating medical products using 3D printers. The guidance details the agency’s stance on device design, testing, and quality system requirements.
For a relatively new technology, 3D printing has a wide range of clinical applications, such as building functionally accurate replicas of complex anatomical structures and facilitating surgery simulations to restore hearing loss, remove stroke clots, and repair hip disorders. The rapid evolution of this technique has led the FDA to release an early policy framework to help manufacturers bring 3D-printed models to the market more efficiently.
Nano Global Corp. (Austin, Texas) has said it is developing a chip using intellectual property from ARM to produce molecular data and to help identify health issues such as infectious diseases and cancer.
The system-on-chip (SoC) will produce secure molecular data that can be used in the recognition and analysis of health threats caused by pathogens and other living organisms.
Combined with the company’s scientific technology platform, the chip leverages advances in nanotechnology, optics, artificial intelligence ], blockchain authentication, and edge computing to access and analyze molecular-level data in real time.
Click here for more…